Finance

Aida Pharmaceuticals reports 12.4% increase in revenue

Published in Lab Law Weekly, December 15th, 2006

Aida Pharmaceuticals, Inc. (AIDA), one of mainland China's leading pharmaceutical companies, announced the company's financial results for the third quarter ended September 30, 2006.

The company reported its EPS doubled, its net income more than doubled and its gross margins improved sequentially during the third quarter. Management believes this positive trend in performance will remain intact in future quarters.

Revenues for the third quarter ended September 30, 2006 totaled $7,023,891, a 12.4% increase from revenues of $6,249,343 for the quarter ended September 30, 2005 and a sequential decrease of 3.6% from revenues of $7,284,888 for the quarter...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Law Weekly

Source: Lab Law Weekly (2006-12-15)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry